| Financial Year |
March 31 2023 |
| Monetary Funds |
307,674,366.86 |
| Held-for-trading Financial Assets |
584,350,625.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
617,340,865.90 |
| Advances to Suppliers |
9,175,569.01 |
| Other Receivables |
93,151,265.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
14,202,678.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,557,416.79 |
| Total Current Assets |
1,650,452,787.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
188,921,323.05 |
| Investment Properties |
23,707,358.63 |
| Fixed Assetes |
46,724,820.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,293,277.16 |
| R&D expenses |
-- |
| Goodwill |
236,394,518.56 |
| Long-Term Deferred and Prepaid Expenses |
35,425,988.41 |
| Deferred Income Tax Assets |
15,325,099.92 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
673,095,707.71 |
| Total Assets |
2,323,548,494.78 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
326,596,163.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,898,717.37 |
| Taxes Payable |
33,496,885.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
442,583,033.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,669,342.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,158,367,096.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,348,863.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
70,920,926.92 |
| Total Liabilities |
1,229,288,023.43 |
| Paid-In Capital(Or Share Stock) |
187,777,779.00 |
| Capital Surplus |
259,402,004.64 |
| Surplus Reserve |
75,844,932.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
544,984,547.76 |
| Minority Stockholder's Interest |
26,251,207.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,068,009,263.96 |
| Owner's Equity（Stockholder's Equity） |
1,094,260,471.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,323,548,494.78 |
